atorvastatin has been researched along with Alveolar Bone Atrophy in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayas, B; Balli, U; Cetinkaya, BO; Erdogan, D; Keles, GC; Mercan, U | 1 |
| Alencar, NM; Benevides, NM; Goes, P; Lima, V; Melo, IM; Ribeiro, RA; Silva, LM | 1 |
| Alves, Mdo S; de Araújo Júnior, RF; de Araújo, AA; de Moura, LM; de Souza, LB; Rocha, HO; Souza, TO; Torres, KP | 1 |
| Alexandre, JT; Brito, GA; Chaves, HV; Freitas, R; Furlaneto, F; Goes, P; Linhares, EV; Lisboa, MR; Marques, M; Martins, C; Ribeiro, I; Sousa, LH; Val, D | 1 |
| Guruprasad, CN; Kumari, M; Martande, SS; Pradeep, AR; Singh, SP; Suke, DK | 1 |
| Kumari, M; Martande, SS; Naik, SB; Pradeep, AR | 1 |
| Espinosa-Chávez, EJ; Fajardo, ME; Rocha, ML; Sánchez-Marin, FJ | 1 |
| Goes, P; Lima, AP; Lima, V; Melo, IM; Rêgo, RO | 1 |
| Kumari, M; Martande, SS; Naik, SB; Pradeep, AR; Rao, NS | 1 |
4 trial(s) available for atorvastatin and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Platelet-Rich Fibrin Combined With 1.2% Atorvastatin for Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial.
Topics: Alveolar Bone Loss; Atorvastatin; Chronic Periodontitis; Fibrin; Humans; Platelet-Rich Fibrin | 2016 |
Efficacy of Subgingivally Delivered 1.2% Atorvastatin in the Treatment of Chronic Periodontitis in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Clinical Trial.
Topics: Alveolar Bone Loss; Anti-Bacterial Agents; Atorvastatin; Chronic Periodontitis; Dental Scaling; Diabetes Mellitus, Type 2; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Periodontal Index; Root Planing | 2016 |
Effect of atorvastatin on chronic periodontitis: a randomized pilot study.
Topics: Adult; Alveolar Bone Loss; Anticholesteremic Agents; Atorvastatin; Chronic Periodontitis; Dental Plaque; Dental Scaling; Double-Blind Method; Female; Gingival Recession; Heptanoic Acids; Humans; Lipids; Male; Middle Aged; Pilot Projects; Pyrroles; Radiography, Dental, Digital; Statistics, Nonparametric; Tooth Mobility | 2010 |
Clinical efficacy of subgingivally delivered 1.2% atorvastatin in chronic periodontitis: a randomized controlled clinical trial.
Topics: Administration, Topical; Adult; Alveolar Bone Loss; Atorvastatin; Chronic Periodontitis; Combined Modality Therapy; Dental Plaque Index; Dental Scaling; Female; Follow-Up Studies; Gels; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Osteogenesis; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Placebos; Pyrroles; Root Planing; Treatment Outcome | 2013 |
5 other study(ies) available for atorvastatin and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Assessment of vascular endothelial growth factor and matrix metalloproteinase-9 in the periodontium of rats treated with atorvastatin.
Topics: Administration, Oral; Administration, Topical; Alveolar Bone Loss; Alveolar Process; Animals; Atorvastatin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Male; Matrix Metalloproteinase 9; Periodontal Attachment Loss; Periodontal Ligament; Periodontitis; Protective Agents; Pyrroles; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A | 2014 |
Low-dose combination of alendronate and atorvastatin reduces ligature-induced alveolar bone loss in rats.
Topics: Acid Phosphatase; Alanine Transaminase; Alendronate; Alkaline Phosphatase; Alveolar Bone Loss; Animals; Aspartate Aminotransferases; Atorvastatin; Body Weight; Bone Density Conservation Agents; Dental Cementum; Gingiva; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infusions, Parenteral; Injections, Subcutaneous; Isoenzymes; Leukocyte Disorders; Leukocytes; Leukocytosis; Male; Monocytes; Neutrophils; Peroxidase; Pyrroles; Rats, Wistar; Root Resorption; Tartrate-Resistant Acid Phosphatase | 2014 |
Atorvastatin decreases bone loss, inflammation and oxidative stress in experimental periodontitis.
Topics: Alveolar Bone Loss; Animals; Atorvastatin; Heptanoic Acids; Inflammation; Male; Oxidative Stress; Periodontitis; Pyrroles; Rats; Rats, Wistar | 2013 |
Effects of Atorvastatin on Periodontitis of Rats Subjected to Glucocorticoid-Induced Osteoporosis.
Topics: Alveolar Bone Loss; Animals; Atorvastatin; Gene Expression; Glucocorticoids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Osteoporosis; Periodontitis; Rats; Rats, Wistar | 2016 |
Effect of Atorvastatin in radiographic density on alveolar bone loss in wistar rats.
Topics: Alveolar Bone Loss; Analysis of Variance; Animals; Atorvastatin; Bone Density; Disease Models, Animal; Dose-Response Relationship, Drug; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Maxilla; Periodontitis; Pyrroles; Radiography, Dental, Digital; Rats; Rats, Wistar; Statistics, Nonparametric | 2010 |